Sandy Elbitar

626 total citations
12 papers, 194 citations indexed

About

Sandy Elbitar is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sandy Elbitar has authored 12 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sandy Elbitar's work include Lipoproteins and Cardiovascular Health (11 papers), Lipid metabolism and disorders (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Sandy Elbitar is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Lipid metabolism and disorders (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Sandy Elbitar collaborates with scholars based in Lebanon, France and Canada. Sandy Elbitar's co-authors include Youmna Ghaleb, Cathérine Boileau, Marianne Abifadel, Mathilde Varret, Petra El Khoury, Jean‐Pierre Rabès, Melody Chemaly, Nabil G. Seidah, Éric Bruckert and Valérie Carreau and has published in prestigious journals such as Scientific Reports, Atherosclerosis and Diabetes Obesity and Metabolism.

In The Last Decade

Sandy Elbitar

12 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandy Elbitar Lebanon	7	165	39	33	29	29	12	194
Youmna Ghaleb Lebanon	7	165 1.0×	39 1.0×	33 1.0×	26 0.9×	29 1.0×	11	191
Merel L. Hartgers Netherlands	9	236 1.4×	39 1.0×	29 0.9×	46 1.6×	55 1.9×	19	268
Amy E. Levenson United States	8	151 0.9×	74 1.9×	105 3.2×	40 1.4×	24 0.8×	11	299
Pin Wang China	9	177 1.1×	46 1.2×	38 1.2×	10 0.3×	15 0.5×	23	253
Donald Moshen Tanyanyiwa South Africa	5	250 1.5×	46 1.2×	70 2.1×	33 1.1×	42 1.4×	12	327
Francine Petrides Australia	6	166 1.0×	39 1.0×	23 0.7×	37 1.3×	34 1.2×	7	199
Ryo Kawakami Japan	9	73 0.4×	34 0.9×	122 3.7×	75 2.6×	28 1.0×	21	275
Julius L. Katzmann Germany	11	220 1.3×	74 1.9×	69 2.1×	86 3.0×	48 1.7×	31	345
Vincenza Valenti Italy	10	195 1.2×	134 3.4×	65 2.0×	174 6.0×	90 3.1×	12	360
Ana Margarida Medeiros Portugal	10	333 2.0×	89 2.3×	45 1.4×	70 2.4×	109 3.8×	27	403

Countries citing papers authored by Sandy Elbitar

Since Specialization

Citations

This map shows the geographic impact of Sandy Elbitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy Elbitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy Elbitar more than expected).

Fields of papers citing papers by Sandy Elbitar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandy Elbitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy Elbitar. The network helps show where Sandy Elbitar may publish in the future.

Co-authorship network of co-authors of Sandy Elbitar

This figure shows the co-authorship network connecting the top 25 collaborators of Sandy Elbitar. A scholar is included among the top collaborators of Sandy Elbitar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandy Elbitar. Sandy Elbitar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ghaleb, Youmna, Sandy Elbitar, S Jambart, et al.. (2022). Low circulating PCSK9 levels in LPL homozygous children with chylomicronemia syndrome in a syrian refugee family in Lebanon. Frontiers in Genetics. 13. 961028–961028. 1 indexed citations

Gannagé‐Yared, Marie‐Hélène, Sandy Elbitar, Youmna Ghaleb, et al.. (2022). Circulating PCSK9 Linked to Dyslipidemia in Lebanese Schoolchildren. Metabolites. 12(6). 504–504. 1 indexed citations

Ghaleb, Youmna, Sandy Elbitar, Georges Halaby, et al.. (2021). Identification of a Variant in APOB Gene as a Major Cause of Hypobetalipoproteinemia in Lebanese Families. Metabolites. 11(9). 564–564. 3 indexed citations

Elbitar, Sandy, Delia Susan‐Resiga, Youmna Ghaleb, et al.. (2018). New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia. Scientific Reports. 8(1). 1943–1943. 25 indexed citations

Extramiana, Fabrice, Olivier Milleron, Sandy Elbitar, et al.. (2018). High prevalence of ventricular repolarization abnormalities in people carrying TGFβR2 mutations. Scientific Reports. 8(1). 13019–13019. 3 indexed citations

Khoury, Petra El, Philippe Couvert, Sandy Elbitar, et al.. (2018). Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1. Journal of clinical lipidology. 12(6). 1374–1382. 10 indexed citations

Ghaleb, Youmna, Sandy Elbitar, Petra El Khoury, et al.. (2018). Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?. European Journal of Human Genetics. 26(4). 570–578. 18 indexed citations

Khoury, Petra El, Sandy Elbitar, Youmna Ghaleb, et al.. (2017). PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies. Current Atherosclerosis Reports. 19(12). 49–49. 22 indexed citations

Khoury, Petra El, Ronan Roussel, Frédéric Fumeron, et al.. (2017). Plasma proprotein‐convertase‐subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes. Diabetes Obesity and Metabolism. 20(4). 943–953. 14 indexed citations

10.

Khoury, Petra El, Ronan Roussel, Frédéric Fumeron, et al.. (2017). Plasma PCSK9 and cardiovascular events in type 2 diabetes. Atherosclerosis. 263. e81–e81. 1 indexed citations

11.

Elbitar, Sandy, Petra El Khoury, Youmna Ghaleb, et al.. (2016). Proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015). Expert Opinion on Therapeutic Patents. 26(12). 1377–1392. 20 indexed citations

12.

Abifadel, Marianne, Sandy Elbitar, Petra El Khoury, et al.. (2014). Living the PCSK9 Adventure: from the Identification of a New Gene in Familial Hypercholesterolemia Towards a Potential New Class of Anticholesterol Drugs. Current Atherosclerosis Reports. 16(9). 439–439. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact